Elevance Health Reports Strong Q1 2025 Financial Results

Details

The company reported an adjusted operating gain of $3.3 billion, up 4.1% year-over-year, and diluted EPS of $9.61. Elevance Health also reaffirmed its FY 2025 adjusted diluted EPS guidance of $34.15 to $34.85. Additionally, the company returned $1.3 billion of capital to shareholders in Q1 2025 through share repurchases and dividends.

Items reported

Exhibits (1)

About Elevance Health Inc.

Elevance Health Inc., formerly known as Anthem, is a prominent health insurance company in the United States. Its primary function is to provide a wide range of health insurance products and related services to a diverse customer base, including individuals, families, and businesses. Elevance Health focuses on enhancing health and well-being by offering managed care plans tailored to the varying needs of its clients. With a robust portfolio, Elevance Health caters to multiple sectors within the healthcare industry, influencing stakeholders such as healthcare providers, pharmaceutical companies, and medical technology firms. The company plays a critical role in the healthcare market by negotiating coverage terms, managing costs, and ensuring policyholders have access to necessary medical services. As one of the largest health insurers in the nation, Elevance Health holds significant market influence, contributing to shaping healthcare policies and practices through its vast network and strategic partnerships. By leveraging technology and data analytics, the company aims to improve patient outcomes, streamline insurance processes, and foster advancements in personalized healthcare solutions.